• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个无N-myc扩增的神经母细胞瘤细胞系中N-myc蛋白半衰期延长。

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.

作者信息

Cohn S L, Salwen H, Quasney M W, Ikegaki N, Cowan J M, Herst C V, Kennett R H, Rosen S T, DiGiuseppe J A, Brodeur G M

机构信息

Department of Pediatrics, Northwestern University Medical Center, Chicago, IL 60614.

出版信息

Oncogene. 1990 Dec;5(12):1821-7.

PMID:2284101
Abstract

Genomic amplification of the oncogene N-myc is associated with rapid tumor progression and poor prognosis in patients with neuroblastoma (NB). However, 40% of NBs which lack N-myc amplification are also clinically aggressive. Factors other than N-myc copy number must therefore play a role in determining tumor progression in these NBs. We have established an unusual human NB cell line (NBL-S) from the primary tumor of a patient with rapidly progressive disease which lacks N-myc amplification. The doubling time in vitro (48 h) and the time from injection of 2 x 10(7) cells to detectable tumors in nude mice (46 days) in similar to NB cell lines with amplified N-myc. However, karyotype analysis reveals no evidence of double minutes (DMs), homogeneously staining regions (HSRs), or chromosome 1p deletions, features commonly seen in NB cell lines. The cells have the cell surface phenotype typical of N-myc amplified NB (HLA-A,B,C negative and HSAN 1.2 positive), and similar to other NB cell lines, N-myc RNA and protein are expressed. Interestingly, the half-life of the N-myc protein in NBL-S is prolonged (approximately 100 min) compared to the short N-myc protein half-life previously described in N-myc amplified NB cell lines (approximately 30 min). Because N-myc protein is thought to have a regulatory role, prolongation of the half-life of this protein may be an important factor in the regulation of growth in NBs which lack N-myc amplification and rapidly progress.

摘要

致癌基因N - myc的基因组扩增与神经母细胞瘤(NB)患者的肿瘤快速进展及预后不良相关。然而,40%未发生N - myc扩增的NB在临床上也具有侵袭性。因此,除了N - myc拷贝数之外的其他因素必定在这些NB的肿瘤进展中发挥作用。我们从一名患有快速进展性疾病且未发生N - myc扩增的患者的原发性肿瘤中建立了一种不同寻常的人类NB细胞系(NBL - S)。其体外倍增时间(48小时)以及将2×10⁷个细胞注射到裸鼠体内至可检测到肿瘤的时间(46天)与N - myc扩增的NB细胞系相似。然而,核型分析未发现双微体(DMs)、均匀染色区(HSRs)或1号染色体缺失的证据,这些是NB细胞系中常见的特征。这些细胞具有N - myc扩增的NB典型的细胞表面表型(HLA - A、B、C阴性且HSAN 1.2阳性),并且与其他NB细胞系一样,表达N - myc RNA和蛋白。有趣的是,与之前在N - myc扩增的NB细胞系中描述的较短的N - myc蛋白半衰期(约30分钟)相比,NBL - S中N - myc蛋白的半衰期延长(约100分钟)。由于N - myc蛋白被认为具有调节作用,该蛋白半衰期的延长可能是在未发生N - myc扩增且快速进展的NB中调节生长的一个重要因素。

相似文献

1
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.在一个无N-myc扩增的神经母细胞瘤细胞系中N-myc蛋白半衰期延长。
Oncogene. 1990 Dec;5(12):1821-7.
2
Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.局限性神经母细胞瘤中N-myc基因扩增与预后的不相关性:一项儿科肿瘤学组研究
Cancer Res. 1995 Feb 15;55(4):721-6.
3
N-myc amplification and cell proliferation rate in human neuroblastoma.人神经母细胞瘤中的N-myc扩增与细胞增殖率
J Pathol. 1997 Nov;183(3):339-44. doi: 10.1002/(SICI)1096-9896(199711)183:3<339::AID-PATH935>3.0.CO;2-T.
4
In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells.人神经母细胞瘤细胞中N-myc与HLA I类RNA稳态水平的体外调节及关系
Cancer Res. 1990 Dec 1;50(23):7532-6.
5
Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.凋亡抑制蛋白bcl-2在神经母细胞瘤中的表达与不良组织学及N-myc扩增相关。
Am J Pathol. 1993 Dec;143(6):1543-50.
6
N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.N- myc对人神经母细胞瘤细胞系中I型胰岛素样生长因子受体的调控
Cancer Res. 1999 Jun 15;59(12):2898-902.
7
Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.1号染色体1p上一个HuD等位基因的缺失促使人类神经母细胞瘤细胞中N - myc原癌基因发生扩增。
Oncogene. 2006 Feb 2;25(5):706-12. doi: 10.1038/sj.onc.1209095.
8
Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.神经母细胞瘤肿瘤及细胞系中N-myc与MAX表达之间缺乏相关性:对N-myc-MAX复合物形成的影响。
Cancer Res. 1994 Apr 15;54(8):2251-5.
9
Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.整合素在有或无N - myc扩增的人神经母细胞瘤细胞以及异位/原位裸鼠肿瘤中的表达。
Exp Cell Res. 1994 Jul;213(1):156-63. doi: 10.1006/excr.1994.1185.
10
Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.神经母细胞瘤细胞系中的缺失图谱表明,1p35 - 36区域存在两个不同的肿瘤抑制基因,其中只有一个与N - myc扩增相关。
Oncogene. 1995 Jan 19;10(2):291-7.

引用本文的文献

1
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures.根据间充质和肾上腺素能特征,描述高危神经母细胞瘤患者 T 细胞炎症与结局的关系。
Cancer Res Commun. 2024 Aug 1;4(8):2255-2266. doi: 10.1158/2767-9764.CRC-24-0214.
2
MYCN and HIF-1 directly regulate expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.MYCN 和 HIF-1 直接调控 的表达,以控制 5-羟甲基胞嘧啶的获得,并增强低氧条件下神经母细胞瘤细胞的迁移。
Epigenetics. 2022 Dec;17(13):2056-2074. doi: 10.1080/15592294.2022.2106078. Epub 2022 Aug 8.
3
EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation.
EZH2 耗竭增强了 MYC 降解,抑制了神经母细胞瘤和小细胞癌的肿瘤形成。
Nat Commun. 2022 Jan 10;13(1):12. doi: 10.1038/s41467-021-27609-6.
4
Reduced Granule Cell Proliferation and Molecular Dysregulation in the Cerebellum of Lysosomal Acid Phosphatase 2 (ACP2) Mutant Mice.溶酶体酸性磷酸酶 2 (ACP2) 突变小鼠小脑颗粒细胞增殖减少和分子失调。
Int J Mol Sci. 2021 Mar 15;22(6):2994. doi: 10.3390/ijms22062994.
5
Epigenomic profiling of neuroblastoma cell lines.神经母细胞瘤细胞系的表观基因组分析。
Sci Data. 2020 Apr 14;7(1):116. doi: 10.1038/s41597-020-0458-y.
6
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.母系胚胎亮氨酸拉链激酶(MELK):神经母细胞瘤的一个潜在治疗靶点。
Mol Cancer Ther. 2019 Mar;18(3):507-516. doi: 10.1158/1535-7163.MCT-18-0819. Epub 2019 Jan 23.
7
The MYCN Protein in Health and Disease.健康与疾病中的MYCN蛋白
Genes (Basel). 2017 Mar 30;8(4):113. doi: 10.3390/genes8040113.
8
Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.视黄酸和转化生长因子-β信号协同作用以克服MYCN诱导的类维生素A耐药性。
Genome Med. 2017 Feb 10;9(1):15. doi: 10.1186/s13073-017-0407-3.
9
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.富含半胱氨酸的酸性分泌蛋白(SPARC)通过调节与脂肪酸结合的白蛋白的转运来诱导神经母细胞瘤中的脂毒性。
Oncotarget. 2016 Nov 22;7(47):77696-77706. doi: 10.18632/oncotarget.12773.
10
Wnt signalling is a bi-directional vulnerability of cancer cells.Wnt信号传导是癌细胞的双向脆弱点。
Oncotarget. 2016 Sep 13;7(37):60310-60331. doi: 10.18632/oncotarget.11203.